Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Leukemia 3Myelodysplastic Syndromes 2Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myeloid 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Biphenotypic, Acute 1Hematologic Neoplasms 1Congenital Abnormalities 1Blast Crisis 1

Interventions

fludarabine phosphate 28Peripheral Blood Stem Cell Transplantation 25Cyclophosphamide 24Whole-Body Irradiation 22Busulfan 22Tacrolimus 19Mycophenolic Acid 19Methotrexate 15Antilymphocyte Serum 13Cyclosporine 12Melphalan 9Filgrastim 9Cytarabine 9Etoposide 8Cord Blood Stem Cell Transplantation 7fludarabine 6Thiotepa 6Methylprednisolone 6Imatinib Mesylate 5Granulocyte Colony-Stimulating Factor 5thymoglobulin 4merphos 4Sirolimus 4Rituximab 4Radiotherapy 4Flow Cytometry 4Dexamethasone 4Dasatinib 4Cyclosporins 4Calcium Dobesilate 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Blast Crisis × Homoharringtonine × Clear all
NCT00114959 2015-01-15

Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)

Teva Branded Pharmaceutical Products R&D, Inc.

Phase 2 Terminated
15 enrolled 6 charts
MyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Leukemia, Myeloid, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡